Insider Transactions in Q1 2022 at Artivion, Inc. (AORT)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 17
2022
|
Marshall S. Stanton SVP, Clinical & MD Affair |
BUY
Grant, award, or other acquisition
|
Direct |
2,603
+17.69%
|
-
|
|
Feb 10
2022
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
10,639
-3.38%
|
$180,863
$17.86 P/Share
|
|
Feb 10
2022
|
James P Mackin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,639
+3.27%
|
$117,029
$11.0 P/Share
|
|
Feb 09
2022
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
10,638
-3.38%
|
$191,484
$18.14 P/Share
|
|
Feb 09
2022
|
James P Mackin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+3.27%
|
$117,018
$11.0 P/Share
|
|
Feb 08
2022
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
10,638
-3.38%
|
$180,846
$17.75 P/Share
|
|
Feb 08
2022
|
James P Mackin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+3.27%
|
$117,018
$11.0 P/Share
|
|
Feb 07
2022
|
James P Mackin President & CEO |
SELL
Open market or private sale
|
Direct |
10,638
-3.38%
|
$180,846
$17.3 P/Share
|
|
Feb 07
2022
|
James P Mackin President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+3.27%
|
$117,018
$11.0 P/Share
|